Koskinen P - Search Results

1

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Manninen V, Elo MO, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, et al. Manninen V, et al. Among authors: koskinen p. JAMA. 1988 Aug 5;260(5):641-51. JAMA. 1988. PMID: 3164788 Clinical Trial.

2

The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.

Huttunen JK, Heinonen OP, Manninen V, Koskinen P, Hakulinen T, Teppo L, Mänttäri M, Frick MH. Huttunen JK, et al. Among authors: koskinen p. J Intern Med. 1994 Jan;235(1):31-9. doi: 10.1111/j.1365-2796.1994.tb01029.x. J Intern Med. 1994. PMID: 8283157 Clinical Trial.

3

The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up.

Heinonen OP, Huttunen JK, Manninen V, Mänttäri M, Koskinen P, Tenkanen L, Frick MH. Heinonen OP, et al. Among authors: koskinen p. J Intern Med. 1994 Jan;235(1):41-9. doi: 10.1111/j.1365-2796.1994.tb01030.x. J Intern Med. 1994. PMID: 8283158 Clinical Trial.

4

Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population.

Frick MH, Heinonen OP, Huttunen JK, Koskinen P, Mänttäri M, Manninen V. Frick MH, et al. Among authors: koskinen p. Ann Med. 1993 Feb;25(1):41-5. doi: 10.3109/07853899309147855. Ann Med. 1993. PMID: 8435186 Clinical Trial.

5

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.

Koskinen P, Mänttäri M, Manninen V, Huttunen JK, Heinonen OP, Frick MH. Koskinen P, et al. Diabetes Care. 1992 Jul;15(7):820-5. doi: 10.2337/diacare.15.7.820. Diabetes Care. 1992. PMID: 1516498 Clinical Trial.

6

Leukocytes as a coronary risk factor in a dyslipidemic male population.

Mänttäri M, Manninen V, Koskinen P, Huttunen JK, Oksanen E, Tenkanen L, Heinonen OP, Frick MH. Mänttäri M, et al. Among authors: koskinen p. Am Heart J. 1992 Apr;123(4 Pt 1):873-7. doi: 10.1016/0002-8703(92)90690-w. Am Heart J. 1992. PMID: 1549995

7

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH. Manninen V, et al. Among authors: koskinen p. Circulation. 1992 Jan;85(1):37-45. doi: 10.1161/01.cir.85.1.37. Circulation. 1992. PMID: 1728471

8

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.

Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Mänttäri M, Manninen V, Huttunen JK. Jauhiainen M, et al. Among authors: koskinen p. Atherosclerosis. 1991 Jul;89(1):59-67. doi: 10.1016/0021-9150(91)90007-p. Atherosclerosis. 1991. PMID: 1837713

9

The Helsinki Heart Study: central findings and clinical implications.

Huttunen JK, Manninen V, Mänttäri M, Koskinen P, Romo M, Tenkanen L, Heinonen OP, Frick MH. Huttunen JK, et al. Among authors: koskinen p. Ann Med. 1991 Apr;23(2):155-9. doi: 10.3109/07853899109148041. Ann Med. 1991. PMID: 2069792 Clinical Trial.

10

Lipoproteins and coronary heart disease in the Helsinki Heart Study.

Mänttäri M, Huttunen JK, Koskinen P, Manninen V, Tenkanen L, Heinonen OP, Frick MH. Mänttäri M, et al. Among authors: koskinen p. Eur Heart J. 1990 Dec;11 Suppl H:26-31. doi: 10.1093/eurheartj/11.suppl_h.26. Eur Heart J. 1990. PMID: 2073911 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

450 results

Search Page